https://japsr.in/index.php/journal <p>Journal of Applied Pharmaceutical Sciences and Research (JAPSR) is a multi-disciplinary international, peer-reviewed, open access journal devoted to various segments of pharmaceutical and applied sciences. It’s a quarterly published journal that publishes quality manuscripts (original research, reviews, short communications, mini reviews, case studies and conference proceedings) relevant to the various fields of Pharmaceutical and Applied Sciences.</p> en-US <p>All the articles published in JAPSR are distributed under a creative commons license (<a href="https://creativecommons.org/licenses/by-nc-sa/4.0/"><span class="tool-identifier">CC BY-NC-SA 4.0</span></a>)</p> <p><strong>Under this license, you are free to:</strong></p> <ul> <li class="show"><strong>Share</strong>- copy and redistribute the material in any medium or format for any purpose, even commercially.</li> <li class="show"><strong>Adapt</strong>- remix, transform, and build upon the material for any purpose, even commercially.</li> </ul> <p>The licensor cannot revoke these freedoms as long as you follow the license terms.</p> <ul> <li class="cc-by"><strong>Attribution&nbsp;</strong>— You must give&nbsp;<a id="src-appropriate-credit" href="https://creativecommons.org/licenses/by-nc-sa/4.0/#ref-appropriate-credit">appropriate credit&nbsp;</a>, provide a link to the license, and&nbsp;<a id="src-indicate-changes" href="https://creativecommons.org/licenses/by-nc-sa/4.0/#ref-indicate-changes">indicate if changes were made&nbsp;</a>. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</li> <li class="cc-nc"><strong>NonCommercial&nbsp;</strong>— You may not use the material for&nbsp;<a id="src-commercial-purposes" href="https://creativecommons.org/licenses/by-nc-sa/4.0/#ref-commercial-purposes">commercial purposes&nbsp;</a>.</li> <li class="cc-sa"><strong>ShareAlike&nbsp;</strong>— If you remix, transform, or build upon the material, you must distribute your contributions under the&nbsp;<a id="src-same-license" href="https://creativecommons.org/licenses/by-nc-sa/4.0/#ref-same-license">same license&nbsp;</a>as the original.</li> <li><strong>No additional restrictions&nbsp;</strong>— You may not apply legal terms or&nbsp;<a id="src-technological-measures" href="https://creativecommons.org/licenses/by-nc-sa/4.0/#ref-technological-measures">technological measures&nbsp;</a>that legally restrict others from doing anything the license permits.</li> </ul> <p><strong>Copyright policy</strong></p> <p>The journal allows the author(s) to hold the copyright of their work. That means the authors do not need to transfer the copyright of their work to the journal. However, the authors grant JAPSR a license to publish the article and identify itself as the original publisher.</p> <p><strong>Licensing policy</strong></p> <p>The journal allows the author(s) to hold the copyright of their work. That means the authors do not need to transfer the copyright of their work to the journal. However, the authors grant JAPSR a license to publish the article and identify itself as the original publisher.</p> editor.japsr@gmail.com (Managing Editor) pradeep@mripub.com (Editor Office) Wed, 12 Aug 2026 00:00:00 +0530 OJS 3.1.1.4 http://blogs.law.harvard.edu/tech/rss 60 https://japsr.in/index.php/journal/article/view/437 <p>Background: Acute myocardial infarction (AMI) remains one of the leading causes of morbidity and mortality worldwide. Overweight<br>and obesity have emerged as major modifiable risk factors for cardiovascular disease because of their association with hypertension,<br>diabetes mellitus, dyslipidaemia, and chronic inflammation. However, data regarding the proportion of overweight and obese individuals<br>among patients with AMI in the Indian population remain limited. Objectives: To determine the prevalence of overweight and obesity<br>among patients diagnosed with acute myocardial infarction and to evaluate their association with major cardiovascular risk factors in<br>a tertiary care centre. Methods: A hospital-based observational cross-sectional study was conducted among 100 consecutive patients<br>diagnosed with acute myocardial infarction. Socio-demographic characteristics, clinical profile, anthropometric measurements, and<br>cardiovascular risk factors were recorded using a predesigned case record form. Body mass index (BMI) was calculated and classified<br>according to World Health Organization criteria. Data were analysed using descriptive statistics, and associations between obesity and<br>cardiovascular risk factors were evaluated using the Chi-square test. A p-value of &lt;0.05 was considered statistically significant. Results: The<br>majority of patients belonged to the 40–59 years age group (60%), with a male predominance (68%). Forty-eight percent of participants<br>were overweight, while 26% were obese, indicating that 74% of patients had excess body weight. Smoking was the most prevalent<br>cardiovascular risk factor, followed by hypertension, diabetes mellitus, alcohol consumption, sedentary lifestyle, obesity, and positive<br>family history. Although hypertension was more frequent among obese patients, the association between obesity and hypertension was<br>not statistically significant (χ² = 0.8497, p = 0.3566). Conclusion: Overweight and obesity were highly prevalent among patients with<br>acute myocardial infarction and were frequently associated with multiple cardiovascular risk factors. Early identification of excess body<br>weight and comprehensive risk factor modification may contribute significantly to reducing the burden of acute myocardial infarction.</p> Snigdha Bhowmik, Ameet Fadia, Soham Kishor Gholba ##submission.copyrightStatement## https://japsr.in/index.php/journal/article/view/437 Wed, 12 Aug 2026 00:00:00 +0530